Immune Cell Subsets in SLE Patients Treated with Telitacicept
Immune Cell Subsets in SLE Patients Treated with Telitacicept
Active, not recruiting · NCT06677801 · Registry updated 2024-11-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immune Cell Subsets in SLE Patients Treated with Telitacicept | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Active, not recruiting | Phase 4 | 2024-11-07 | NCT06677801 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 561 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| the second affiliated hospital, Zhejiang University School of medicine | Hangzhou | China | 2 |